Regulation of Liver-Specific Gene Expression
Regulation of Liver-Specific Gene Expression
批准号:
8293335
负责人:
FRANCES M. SLADEK
金额:
$36.81万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-06-16 至 2013-08-31
关键词:
AddressAdultAffectAlternative SplicingAtherosclerosisCell CycleCell Cycle InhibitionCell ProliferationColon CarcinomaCytoplasmDNA BindingDNA Binding DomainDataDevelopmentDiabetes MellitusDietDiseaseDrug Delivery SystemsEssential GenesExonsFetal LiverFundingGene ExpressionGene Expression RegulationGene StructureGene TargetingGenesGenetic TranscriptionGenomeGoalsHemophilia AHepatocyteHumanIntestinesInvestigationKidneyKnowledgeLettersLigandsLinkLiverLiver RegenerationMalignant NeoplasmsMapsMetabolismMolecularMusN-terminalNuclear ReceptorsObesityOutcomePancreasPhosphorylationPhysiologicalPlayProtein IsoformsProteinsPublic HealthRegulationResearchRoleSerineSignal PathwaySignal TransductionStomachStressTechniquesTissuesTranscriptTyrosine Phosphorylationc-myc Genesdesignextracellularfollow-uphuman HNF4A proteinhuman diseasein vivointerestmembermetabolomicsmouse modelmutantpromoterprotein degradationresearch studyresponsetranscription factor
中文摘要
项目摘要
肝细胞核因子4(HNF4)是核内高度保守的成员。
受体(NR)超家族的配体依赖的转录因子。这是一个
必需基因,在早期发育中起关键作用,在成人中也是如此
在肝脏、肾脏、胰腺和肠道。HNF4已直接与
包括糖尿病和血友病在内的几种人类疾病与
对其他疾病,包括动脉粥样硬化和癌症。HNF4是最多的
肝脏中有丰富的转录因子。而许多靶基因都有
被确认为HNF4,最近的基因组规模分析表明有
还有更多的人有待确认。例如,最近的结果表明,
可能是HNF4不同亚型靶基因的差异
由选择性剪接和启动子使用产生。此外,HNF4是
已知是一种高度磷酸化的蛋白质,并对多种内源蛋白做出反应
和细胞外信号;然而,只有少数亚磷酸盐被
绘制了地图并充分刻画了特征。最后,除了它在中介中的作用
新陈代谢方面,越来越多的证据表明,HNF4也可能
在调节细胞周期方面发挥作用。为了解决这些问题,我们
提出以下三个具体目标:1)发现新的HNF4靶基因
使用基因组规模的分析和活体小鼠模型来检查
HNF4亚型的功能差异;2)研究酪氨酸的作用
HNF4功能中的磷酸化;以及3)研究HNF4在
调节细胞周期。拟议中的实验将继续
用一种广谱方法研究HNF4在肝脏特异性基因表达中的作用
一系列现代技术。研究结果将进一步加深我们对
组织特异性基因调控的机制。它们还将提供无价的
关于与HNF4有关的各种人类疾病的信息。
最后,作为潜在的药物靶点,更全面地了解
HNF4靶向的基因以及靶向HNF4的信号通路将
对于开发适当的治疗方法至关重要。项目叙事
我们的研究与公共健康相关,因为它试图破译
肝脏和肠道中基因被启动的机制。这一点很重要
仅仅是为了了解糖尿病、肥胖症、
动脉粥样硬化和癌症,而且还设计了治疗这些疾病的新疗法
疾病。
英文摘要
Project Summary
Hepatocyte nuclear factor 4 (HNF4) is a highly conserved member of the nuclear
receptor (NR) superfamily of ligand-dependent transcription factors. It is an
essential gene, playing a critical role in early development, as well as in the adult
in the liver, kidney, pancreas and intestine. HNF4 has been directly linked to
several human diseases including diabetes and hemophilia and indirectly linked
to others including atherosclerosis and cancer. HNF4 is one of the most
abundant transcription factors in the liver. Whereas many target genes have
been identified for HNF4, recent genome-scale analyses indicate that there are
many more yet to be identified. Recent results indicate, for example, that there
may be differences in the target genes of the different isoforms of HNF4
generated by alternative splicing and promoter usage. Furthermore, HNF4 is
known to be a heavily phosphorylated protein and to respond to a variety of intra-
and extracellular signals; however, only a few of the phosphosites have been
mapped and fully characterized. Finally, in addition to its role in intermediary
metabolism, there is a growing body of evidence indicating that HNF4 may also
play a role in regulating the cell cycle. In order to address these issues, we
propose the following three Specific Aims: 1) Identify new target genes for HNF4
using genome-scale analysis and an in vivo mouse model to examine the
functional differences in HNF4 isoforms; 2) Investigate the role of tyrosine
phosphorylation in HNF4 function; and 3) Investigate the role of HNF4 in
regulating the cell cycle. The proposed experiments will continue the
investigation of the role of HNF4 in liver-specific gene expression using a broad
array of modern techniques. The results will further our understanding of the
mechanisms of tissue-specific gene regulation. They will also provide invaluable
information regarding a variety of human diseases that are linked to HNF4.
Finally, as a potential drug target, a more comprehensive knowledge of the
genes targeted by HNF4, as well as the signaling pathways that target HNF4, will
be essential to developing appropriate therapies. Project Narrative
Our research is relevant to public health because it attempts to decipher the
mechanisms by which genes are turned on in the liver and gut. This is critical not
only for understanding the causes of diseases such as diabetes, obesity,
atherosclerosis and cancer, but also for designing new therapies to treat those
diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Balance between HNF4a isoforms in the carbohydrate-lipid metabolic switch
-
批准号:10663333
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2021
-
负责人:FRANCES M. SLADEK
-
依托单位:
Balance between HNF4a isoforms in the carbohydrate-lipid metabolic switch
-
批准号:10367664
-
项目类别:
-
资助金额:$42.92万
-
财政年份:2021
-
负责人:FRANCES M. SLADEK
-
依托单位:
Nuclear Receptor DNA Binding in Human Physiology and Disease
-
批准号:8619619
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2012
-
负责人:FRANCES M. SLADEK
-
依托单位:
Nuclear Receptor DNA Binding in Human Physiology and Disease
-
批准号:8819128
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2012
-
负责人:FRANCES M. SLADEK
-
依托单位:
Nuclear Receptor DNA Binding in Human Physiology and Disease
-
批准号:8438380
-
项目类别:
-
资助金额:$36.67万
-
财政年份:2012
-
负责人:FRANCES M. SLADEK
-
依托单位:
Nuclear Receptor DNA Binding in Human Physiology and Disease
-
批准号:8258935
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2012
-
负责人:FRANCES M. SLADEK
-
依托单位:
Regulation of Liver-Specific Gene Expression
-
批准号:7837560
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2009
-
负责人:FRANCES M. SLADEK
-
依托单位:
Nuclear Receptor Networks in Human Disease
-
批准号:7892935
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2009
-
负责人:FRANCES M. SLADEK
-
依托单位:
Endogenous HNF4 Ligands in Physiology and Disease
-
批准号:7140268
-
项目类别:
-
资助金额:$21.09万
-
财政年份:2005
-
负责人:FRANCES M. SLADEK
-
依托单位:
Endogenous HNF4 Ligands in Physiology and Disease
-
批准号:6959131
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2005
-
负责人:FRANCES M. SLADEK
-
依托单位:
REGULATION OF LIVER SPECIFIC GENE EXPRESSION
-
批准号:6381125
-
项目类别:
-
资助金额:$23.14万
-
财政年份:1998
-
负责人:FRANCES M. SLADEK
-
依托单位:
REGULATION OF LIVER SPECIFIC GENE EXPRESSION
-
批准号:2594715
-
项目类别:
-
资助金额:$20.82万
-
财政年份:1998
-
负责人:FRANCES M. SLADEK
-
依托单位:
HNF4 Isoforms in Physiology and Disease
-
批准号:8599216
-
项目类别:
-
资助金额:$37.73万
-
财政年份:1998
-
负责人:FRANCES M. SLADEK
-
依托单位:
REGULATION OF LIVER SPECIFIC GENE EXPRESSION
-
批准号:6177610
-
项目类别:
-
资助金额:$22.07万
-
财政年份:1998
-
负责人:FRANCES M. SLADEK
-
依托单位:
Regulation of Liver-Specific Gene Expression
-
批准号:6894017
-
项目类别:
-
资助金额:$38.54万
-
财政年份:1998
-
负责人:FRANCES M. SLADEK
-
依托单位:
Regulation of Liver-Specific Gene Expression
-
批准号:7122573
-
项目类别:
-
资助金额:$1.7万
-
财政年份:1998
-
负责人:FRANCES M. SLADEK
-
依托单位:
Regulation of Liver-Specific Gene Expression
-
批准号:6553255
-
项目类别:
-
资助金额:$35.29万
-
财政年份:1998
-
负责人:FRANCES M. SLADEK
-
依托单位:
HNF4 Isoforms in Physiology and Disease
-
批准号:8719973
-
项目类别:
-
资助金额:$38.0万
-
财政年份:1998
-
负责人:FRANCES M. SLADEK
-
依托单位:
Regulation of Liver-Specific Gene Expression
-
批准号:6612860
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1998
-
负责人:FRANCES M. SLADEK
-
依托单位:
Regulation of Liver-Specific Gene Expression
-
批准号:7455419
-
项目类别:
-
资助金额:$43.61万
-
财政年份:1998
-
负责人:FRANCES M. SLADEK
-
依托单位:
海外基金